EUVIMEDEUVIMED entdecken
Crossref

Farnesoid X receptor deficiency accelerates aging and systemic functional decline in male mice

Jing Yu, Bingbing Fan, Hang Shi, Xiaoyan Gao, Lijun Zhang, Wenlong Nie, Yao Fan, Shishuo Wang, Cheng Huang, Shengjie Fan

Biogerontology · 2026-06 · 27 (3)

DOI: 10.1007/s10522-026-10425-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biogerontology, online erschienen am 01.04.2026. Verfasst von Jing Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. Hauptthemen laut MEDLINE: Receptors, Cytoplasmic and Nuclear, Aging, Longevity. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, Shanghai Magnolia Talent Plan of Shanghai- Pujiang Talents Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging is accompanied by progressive functional decline, and nuclear receptors have become significant modulators of the process. Farnesoid X receptor (FXR), a ligand activated nuclear receptor transcription factor that regulates genes involved in bile acid and metabolic homeostasis, has been implicated in aging, yet genetic evidence remains limited. In this study, we demonstrate that FXR knockout (FXR-/-) mice have significantly shorter lifespan and healthspan than WT mice. FXR deficiency led to aggravated neurodegeneration, impaired motor function, multi-organ deterioration, and profound metabolic imbalance. Transcriptomic profiling further revealed a general dysregulation of aging-related pathways, including suppression of p53 signaling, PI3K-Akt signaling, and xenobiotic metabolism, alongside aberrant activation of bile acid and lipid metabolic flux. These results confirm that FXR is an essential regulator of systemic homeostasis and aging, and provide direct genetic evidence that its loss accelerates physiological decline. Our results highlight FXR as a promising therapeutic target for interventions aimed at preserving healthspan and delaying age-related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Cytoplasmic and NuclearAgingLongevityAnimalsReceptor, Farnesoid X-ActivatedMaleMice, KnockoutMiceSignal TransductionHomeostasisMice, Inbred C57BL

Stichwörter der Autor:innen

AgingDetoxificationFXRMetabolism

Substanzen

Receptors, Cytoplasmic and NuclearReceptor, Farnesoid X-Activated

Autor:innen und Institutionen

  • School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
  • School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. chuang@shutcm.edu.cn.
  • School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. shengjiefan@shutcm.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai
  • Shanghai Magnolia Talent Plan of Shanghai- Pujiang Talents Program
  • Shanghai Eastern Talent Plan

Zitieren

APA

Yu, J., Fan, B., Shi, H., Gao, X., Zhang, L., Nie, W., Fan, Y., Wang, S., Huang, C., & Fan, S. (2026). Farnesoid X receptor deficiency accelerates aging and systemic functional decline in male mice. Biogerontology, 27(3). https://doi.org/10.1007/s10522-026-10425-0

Vancouver

Yu J, Fan B, Shi H, Gao X, Zhang L, Nie W, et al. Farnesoid X receptor deficiency accelerates aging and systemic functional decline in male mice. Biogerontology. 2026;27(3). doi:10.1007/s10522-026-10425-0

BibTeX
@article{Yu2026,
  author = {Yu, Jing and Fan, Bingbing and Shi, Hang and Gao, Xiaoyan and Zhang, Lijun and Nie, Wenlong and Fan, Yao and Wang, Shishuo and Huang, Cheng and Fan, Shengjie},
  title = {Farnesoid X receptor deficiency accelerates aging and systemic functional decline in male mice},
  journal = {Biogerontology},
  year = {2026},
  volume = {27},
  number = {3},
  doi = {10.1007/s10522-026-10425-0}
}
Kostenlos starten →